TETRATHERIX LIMITED

Tetratherix Limited

Equities

TTX

AU0000400574

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 11:54:33 2026-02-12 pm EST			5-day change	1st Jan Change
3.700 ^AUD	-1.07%		-2.63%	+12.80%

Jan. 21	Tetratherix Limited Confirms Appointment of Maurizio Vecchione as Independent Non-Executive Director	CI
Jan. 18	Tetratherix Secures Distribution Deal With Healthcare Product Distributor; Shares Up 3%	MT

Tetratherix Secures Distribution Deal With Healthcare Product Distributor; Shares Up 3%

Published on 01/18/2026 at 10:34 pm EST

MT Newswires

© MT Newswires - 2026

Headlines

	Airbnb posts underwhelming results	05:54am
	AEP: data centre boom lifts profits	Feb. 12
	Moderna in a Spin After FDA Declines to Review Flu Vaccine Candidate	Feb. 11
	Thomson Reuters goes All-out on AI	Feb. 12
	Hermes International: Endurance over excitement	11:23am

Latest news about Tetratherix Limited

Jan. 21	Tetratherix Limited Confirms Appointment of Maurizio Vecchione as Independent Non-Executive Director	CI
Jan. 18	Tetratherix Secures Distribution Deal With Healthcare Product Distributor; Shares Up 3%	MT
Jan. 18	Tetratherix executes global distribution & supply agreement with Henry Schein	RE
Jan. 12	Tetratherix Says Safety Review for Second Patient Group in Surgical Scar Prevention Product Trial Showed No Adverse Events; Shares Jump 5%	MT
Dec. 19	2,190 Ordinary Shares of Tetratherix Limited are subject to a Lock-Up Agreement Ending on 20-DEC-2025.	CI
Dec. 15	Tetratherix Limited Announces Directorate and Management Changes	CI
Dec. 05	101,571 Ordinary Shares of Tetratherix Limited are subject to a Lock-Up Agreement Ending on 6-DEC-2025.	CI
Nov. 30	Tetratherix JV Secures Alcon Funding for Preclinical Development; Shares Rise 8%	MT
Nov. 30	Tetratherix says BioOptix enters agreement with Alcon Research	RE
25-10-27	Tetratherix Says Second Phase of Hydrogel Spacer First In-Human Clinical Investigation Underway	MT
25-10-13	Tetratherix Says Safety Review Committee Confirms No Procedural Related Adverse Events at Trial	MT
25-09-05	28,117 Ordinary Shares of Tetratherix Limited are subject to a Lock-Up Agreement Ending on 6-SEP-2025.	CI
25-09-01	14,059 Ordinary Shares of Tetratherix Limited are subject to a Lock-Up Agreement Ending on 2-SEP-2025.	CI
25-08-13	Tetratherix Secures AU$3.3 Million Australian Government Grant for Synthetic Polymer Production Facility	MT
25-08-13	Tetratherix Limited Announces It Has Been Awarded an Industry Growth Program Grant from the Australian Government	CI

Chart Tetratherix Limited

Duration

Period

Chart Tetratherix Limited

TTX: Dynamic Chart

Company Profile

Employees

15

Sector

Biotechnology & Medical Research

More about the company

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

2

Last Close Price

3.700AUD

Average target price

5.030AUD

Spread / Average Target

+35.95%

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stock Market News
Tetratherix Secures Distribution Deal With Healthcare Product Distributor; Shares Up 3%

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Unlock them now!